Divergence from osteoporosis screening guidelines in older breast cancer patients treated with anti-estrogen therapy: A population-based cohort study
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (251510)
- Canadian Cancer Society Research Institute (700933)
- Quebec Health Research Fund (20300)
This publication has 34 references indexed in Scilit:
- Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort studyBreast Cancer Research and Treatment, 2013
- Patterns of bone density evaluation in a community population treated with aromatase inhibitorsBreast Cancer Research and Treatment, 2012
- Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump InhibitorsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- Predicting Adherence to Tamoxifen for Breast Cancer Adjuvant Therapy and PreventionCancer Prevention Research, 2011
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancerBreast Cancer Research and Treatment, 2010
- Accessibility to health care facilities in Montreal Island: an application of relative accessibility indicators from the perspective of senior and non-senior residentsInternational Journal of Health Geographics, 2010
- Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast CancerJournal of Clinical Oncology, 2009
- Practical guidance for the management of aromatase inhibitor-associated bone lossAnnals of Oncology, 2008
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trialThe Lancet Oncology, 2008
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993